CLASS II Device recall · Reported 25 Jan 2017 · FDA Enforcement Report

Human Lambda Free SPAPlus Kit Product recalled by The Binding Site Group

The Binding Site Group is recalling Human Lambda Free SPAPlus Kit, distributed in 11 states. The recall was initiated on 28 Nov 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #323278, 327963
Quantity recalled1,002

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1050-2017
FDA event ID
76049
Recalling firm
The Binding Site Group, Birmingham
Classification
Class II
Status
Terminated
Recall initiated
28 Nov 2012
FDA classified
19 Jan 2017
Reported
25 Jan 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Device type
Patient Monitors

Timeline

28 Nov 2012Recall initiated by company
19 Jan 2017Classified by FDA+1513 days
25 Jan 2017Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Calibration curve activity has increased over time in the kit lots listed.

Product as listed by the FDA

Human Lambda Free SPAPlus Kit Product Code: LK018.S Freelite aids in the detection and monitoring of Multiple Myeloma and related diseases.

Where it was distributed

U.S. distribution to the following; CA, TX, HI, GA, PA, UT, NY, OK, ID, MA, AZ. Foreign distribution to the following; Australia, Bulgaria, Denmark, Hong Kong, Ireland, Israel, Japan, New Zealand, Taiwan, Belgium, France, Italy, Spain.

ArizonaCaliforniaGeorgiaHawaiiIdahoMassachusettsNew YorkOklahomaPennsylvaniaTexasUtah

Questions about this recall

Why was it recalled?

Calibration curve activity has increased over time in the kit lots listed.

Which lots are affected?

Lot #323278, 327963

Where was it sold?

U.S. distribution to the following; CA, TX, HI, GA, PA, UT, NY, OK, ID, MA, AZ. Foreign distribution to the following; Australia, Bulgaria, Denmark, Hong Kong, Ireland, Israel, Japan, New Zealand, Taiwan, Belgium, France, Italy, Spain.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from The Binding Site Group

All 29

Other Patient Monitors recalls

All 1,014